 Fabienne Gally
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid-Binding Proteins | 6 | 2023 | 62 | 2.600 |
Why?
| | TRPM Cation Channels | 2 | 2018 | 68 | 1.220 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 1137 | 1.030 |
Why?
| | Smoke | 3 | 2017 | 143 | 1.020 |
Why?
| | Pneumonia, Mycoplasma | 4 | 2012 | 33 | 1.010 |
Why?
| | PPAR gamma | 3 | 2022 | 188 | 0.980 |
Why?
| | Mycoplasma pneumoniae | 3 | 2012 | 33 | 0.920 |
Why?
| | Neoplasm Proteins | 2 | 2019 | 401 | 0.900 |
Why?
| | Listeriosis | 2 | 2019 | 60 | 0.810 |
Why?
| | Immunity, Innate | 6 | 2017 | 745 | 0.790 |
Why?
| | Listeria monocytogenes | 2 | 2019 | 110 | 0.780 |
Why?
| | Mucin-5B | 2 | 2022 | 175 | 0.730 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2023 | 2062 | 0.730 |
Why?
| | Radiodermatitis | 1 | 2018 | 7 | 0.680 |
Why?
| | Macrophages | 3 | 2022 | 1324 | 0.660 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2022 | 451 | 0.660 |
Why?
| | Macrophages, Alveolar | 3 | 2021 | 359 | 0.610 |
Why?
| | Inflammation | 5 | 2023 | 2566 | 0.600 |
Why?
| | Glycoproteins | 3 | 2021 | 319 | 0.600 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 155 | 0.580 |
Why?
| | Cytokines | 4 | 2019 | 1900 | 0.560 |
Why?
| | Pneumonia | 3 | 2021 | 592 | 0.490 |
Why?
| | Lung | 8 | 2023 | 3664 | 0.480 |
Why?
| | Down Syndrome | 1 | 2017 | 356 | 0.430 |
Why?
| | Phosphoproteins | 2 | 2011 | 308 | 0.420 |
Why?
| | Epithelial Cells | 3 | 2017 | 963 | 0.410 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 140 | 0.410 |
Why?
| | Bronchi | 1 | 2013 | 242 | 0.400 |
Why?
| | Mice, Knockout | 6 | 2021 | 2680 | 0.400 |
Why?
| | Mice | 17 | 2023 | 15520 | 0.390 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 193 | 0.390 |
Why?
| | Pseudomonas aeruginosa | 2 | 2013 | 305 | 0.390 |
Why?
| | Down-Regulation | 1 | 2013 | 627 | 0.370 |
Why?
| | Mice, Inbred C57BL | 7 | 2018 | 4908 | 0.340 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2008 | 36 | 0.340 |
Why?
| | Respiratory Hypersensitivity | 1 | 2008 | 65 | 0.320 |
Why?
| | Influenza, Human | 1 | 2013 | 554 | 0.300 |
Why?
| | Toll-Like Receptor 2 | 3 | 2013 | 127 | 0.290 |
Why?
| | Oxidative Stress | 1 | 2013 | 1178 | 0.290 |
Why?
| | Bacterial Load | 2 | 2019 | 61 | 0.280 |
Why?
| | Animals | 18 | 2023 | 33381 | 0.280 |
Why?
| | Cells, Cultured | 7 | 2019 | 4077 | 0.280 |
Why?
| | Binding Sites | 2 | 2021 | 1224 | 0.270 |
Why?
| | RNA, Messenger | 3 | 2019 | 2657 | 0.260 |
Why?
| | Allergens | 1 | 2008 | 424 | 0.260 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1346 | 0.250 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 22 | 0.240 |
Why?
| | Transcription Factors | 1 | 2011 | 1570 | 0.230 |
Why?
| | Cell Line | 2 | 2021 | 2707 | 0.230 |
Why?
| | Enhancer Elements, Genetic | 2 | 2021 | 152 | 0.220 |
Why?
| | Gene Expression Regulation | 3 | 2022 | 2445 | 0.220 |
Why?
| | Superoxide Dismutase | 2 | 2015 | 339 | 0.220 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 6 | 0.200 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 6 | 0.200 |
Why?
| | Lysophospholipase | 1 | 2021 | 13 | 0.200 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 26 | 0.200 |
Why?
| | A549 Cells | 1 | 2021 | 48 | 0.200 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 30 | 0.200 |
Why?
| | NF-kappa B | 3 | 2019 | 670 | 0.190 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 368 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 51 | 0.190 |
Why?
| | Lipopolysaccharides | 3 | 2023 | 870 | 0.190 |
Why?
| | Chromatin | 2 | 2021 | 441 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 327 | 0.180 |
Why?
| | Humans | 17 | 2023 | 118972 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 982 | 0.180 |
Why?
| | Th2 Cells | 2 | 2012 | 164 | 0.180 |
Why?
| | Respiratory Mucosa | 2 | 2012 | 254 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 509 | 0.170 |
Why?
| | Blotting, Western | 2 | 2013 | 1194 | 0.170 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 189 | 0.170 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2018 | 129 | 0.170 |
Why?
| | Alpha-Globulins | 1 | 2018 | 21 | 0.160 |
Why?
| | Receptors, Glucocorticoid | 1 | 2019 | 133 | 0.160 |
Why?
| | RNA Polymerase II | 1 | 2021 | 282 | 0.160 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2025 | 0.160 |
Why?
| | Disease Models, Animal | 3 | 2021 | 3730 | 0.160 |
Why?
| | Models, Genetic | 1 | 2021 | 595 | 0.160 |
Why?
| | Dexamethasone | 1 | 2019 | 320 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 3 | 2022 | 2275 | 0.150 |
Why?
| | Mucociliary Clearance | 2 | 2018 | 43 | 0.150 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 136 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 539 | 0.140 |
Why?
| | Disease Progression | 1 | 2023 | 2490 | 0.140 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 197 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 363 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2019 | 502 | 0.140 |
Why?
| | Cell Survival | 1 | 2019 | 1047 | 0.130 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 576 | 0.130 |
Why?
| | Protein Binding | 2 | 2018 | 1975 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2018 | 310 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1171 | 0.120 |
Why?
| | Skin | 1 | 2018 | 657 | 0.120 |
Why?
| | Base Sequence | 1 | 2017 | 2159 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2013 | 161 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 195 | 0.110 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 156 | 0.110 |
Why?
| | Physical Conditioning, Animal | 1 | 2015 | 204 | 0.110 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1158 | 0.110 |
Why?
| | Ovalbumin | 2 | 2012 | 165 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 410 | 0.110 |
Why?
| | Antioxidants | 2 | 2014 | 564 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.100 |
Why?
| | Tobacco Products | 1 | 2013 | 69 | 0.100 |
Why?
| | Heat Shock Transcription Factors | 1 | 2011 | 17 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2012 | 103 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 311 | 0.100 |
Why?
| | Risk Factors | 2 | 2023 | 9000 | 0.100 |
Why?
| | Adaptive Immunity | 1 | 2013 | 161 | 0.100 |
Why?
| | Bronchoalveolar Lavage | 1 | 2011 | 89 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 74 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2013 | 331 | 0.100 |
Why?
| | Cartilage, Articular | 1 | 2015 | 306 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 827 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 330 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2012 | 442 | 0.090 |
Why?
| | Chimera | 1 | 2008 | 60 | 0.080 |
Why?
| | Lead | 1 | 2008 | 47 | 0.080 |
Why?
| | Radiation Protection | 1 | 2008 | 36 | 0.080 |
Why?
| | Models, Animal | 1 | 2009 | 363 | 0.080 |
Why?
| | Antibody Formation | 1 | 2008 | 276 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 255 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2008 | 365 | 0.070 |
Why?
| | Gene Expression | 2 | 2022 | 1489 | 0.070 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 287 | 0.070 |
Why?
| | Immunization | 1 | 2008 | 412 | 0.070 |
Why?
| | Lymph Nodes | 1 | 2008 | 455 | 0.070 |
Why?
| | Male | 4 | 2021 | 57801 | 0.070 |
Why?
| | Receptors, Drug | 1 | 2004 | 13 | 0.070 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2004 | 25 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 788 | 0.060 |
Why?
| | Potassium Channels | 1 | 2004 | 123 | 0.060 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 125 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.060 |
Why?
| | Signal Transduction | 2 | 2019 | 4709 | 0.060 |
Why?
| | Endothelium | 1 | 2023 | 120 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1794 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1206 | 0.050 |
Why?
| | alpha 1-Antitrypsin | 1 | 2023 | 115 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 150 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 281 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 567 | 0.050 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.050 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 11 | 0.050 |
Why?
| | Chitinases | 1 | 2021 | 10 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2021 | 32 | 0.050 |
Why?
| | CD11b Antigen | 1 | 2021 | 59 | 0.050 |
Why?
| | Cell Size | 1 | 2021 | 86 | 0.050 |
Why?
| | Lectins | 1 | 2021 | 50 | 0.050 |
Why?
| | Monocytes | 1 | 2023 | 513 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 324 | 0.050 |
Why?
| | Phagocytosis | 1 | 2021 | 364 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 559 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2158 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 282 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 503 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 732 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 625 | 0.040 |
Why?
| | RNA | 1 | 2022 | 833 | 0.040 |
Why?
| | DNA | 1 | 2022 | 1388 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1233 | 0.030 |
Why?
| | Female | 2 | 2021 | 61564 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 33 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 162 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1670 | 0.030 |
Why?
| | Arginine | 1 | 2014 | 249 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 230 | 0.030 |
Why?
| | Doxycycline | 1 | 2012 | 60 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2015 | 176 | 0.030 |
Why?
| | Running | 1 | 2015 | 227 | 0.030 |
Why?
| | Bone and Bones | 1 | 2015 | 289 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 613 | 0.030 |
Why?
| | Knee Joint | 1 | 2015 | 353 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 642 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 755 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 76 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1882 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1085 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 460 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6412 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 276 | 0.020 |
Why?
| | Sulfonylurea Receptors | 1 | 2004 | 6 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2275 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2004 | 146 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2004 | 338 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1435 | 0.010 |
Why?
|
|
Gally's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|